“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic

Author:

Conway AnnaORCID,Treloar Carla,Crawford Sione,Degenhardt LouisaORCID,Dore Gregory J,Farrell MichaelORCID,Hayllar Jeremy,Grebely JasonORCID,Marshall Alison D.ORCID

Funder

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference53 articles.

1. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington;Amiri;Journal of Substance Abuse Treatment,2018

2. Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges;Arunogiri;Journal of Substance Abuse Treatment,2020

3. Australian Institute of Health and Welfare. National opioid pharmacotherapy statistics annual data collection [Internet]. (2022). [cited 2022 Jul 6]. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics-2019/contents/clients.

4. The current status of opioid maintenance treatment in France: A survey of physicians, patients, and out-of-treatment opioid users;Benyamina;International Journal of General Medicine,2014

5. Disciplining addictions: The bio-politics of methadone and heroin in the U.S. culture;Bourgois;Medicine and Psychiatry,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3